Drug Type Small molecule drug |
Synonyms (±)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate, 1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanol, 4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate + [8] |
Target |
Action agonists |
Mechanism adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (02 May 1980), |
Regulation- |
Molecular FormulaC19H30ClNO5 |
InChIKeyVKFAUCPBMAGVRG-UHFFFAOYSA-N |
CAS Registry64019-93-8 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Dipivefrin Hydrochloride |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Ocular Hypertension | Japan | 20 Sep 1988 | |
| Glaucoma, Open-Angle | United States | 02 May 1980 |
Phase 2 | 47 | (Placebo) | utrwddprpr(vyfdtcxwzi) = tqvxfcihkg qmiscuqlwx (msckiwpggn, citlpnsrqy - cfchtidvre) View more | - | 14 Aug 2019 | ||
(0.25 % Bupivacaine w/ Epinephrine & 4mg Dexamethasone) | utrwddprpr(vyfdtcxwzi) = ipyvaxxwuy qmiscuqlwx (msckiwpggn, xjbryxpwhx - uknzqibnrx) View more |





